India, U.S. Set High-Level Talks Over Drug Quality, IP Issues
This article was originally published in PharmAsia News
Executive Summary
U.S. pharmaceutical companies will have a chance to make their case about drug quality and patent issues when India Prime Minister Narendra Modi holds a teleconference with them on his American trip this month.
U.S. pharmaceutical companies will have a chance to make their case about drug quality and patent issues when India Prime Minister Narendra Modi holds a teleconference with them on his American trip this month. A source said supply and quality of drugs and intellectual property were two key issues certain to be discussed during high-level talks. The source said many players from the pharma industry are expected to be included in discussions. (Click here for more
)
"Modi's Industry Conference In U.S. To Attract Pharma, IT Players" - Business Standard (India) (9/2/2014)